Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03910439 · MORE INFO

Limitations, agreements, and source contact

Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma · Source last updated 2021-05-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
mark.roschewski@nih.gov
organization
National Cancer Institute
phone
240-760-6183
title
Dr. Mark Roschewski
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
mark.roschewski@nih.gov
organization
National Cancer Institute
phone
240-760-6183
title
Dr. Mark Roschewski

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice